Ninfa Candela to Humans
This is a "connection" page, showing publications Ninfa Candela has written about Humans.
Connection Strength
0.100
-
Nwosu BU, Maranda L, Candela N. Vitamin D status in pediatric irritable bowel syndrome. PLoS One. 2017; 12(2):e0172183.
Score: 0.022
-
Cleveland NK, Ghosh S, Kathe N, Umashankar K, Mirchandani K, Hait A, Paul R, Candela N, Fan T, Rubin DT. Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study. J Manag Care Spec Pharm. 2024 Nov; 30(11):1276-1287.
Score: 0.009
-
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 10 03; 30(10):1776-1787.
Score: 0.009
-
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314.
Score: 0.009
-
Chiorean M, Jiang J, Candela N, Chen G, Romdhani H, Latremouille-Viau D, Shi S, Bungay R, Guerin A, Fan T. Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States. Curr Med Res Opin. 2024 05; 40(5):877-885.
Score: 0.009
-
Vu M, Ghosh S, Umashankar K, Weber L, Landis C, Candela N, Chastek B. Comparison of surgery rates in biologic-na?ve patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN. BMC Gastroenterol. 2023 Mar 25; 23(1):87.
Score: 0.008
-
Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. J Pediatr Gastroenterol Nutr. 2023 05 01; 76(5):566-575.
Score: 0.008
-
Ungaro RC, Chou B, Mo J, Ursos L, Twardowski R, Candela N, Colombel JF. Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA. J Crohns Colitis. 2022 Sep 08; 16(9):1405-1414.
Score: 0.008
-
Creo AL, Candela N, Lee MM, Feldman PM. An Unusual Manifestation of Celiac Disease in an Adolescent With Down Syndrome and Graves Disease. J Pediatr Gastroenterol Nutr. 2017 07; 65(1):e20-e22.
Score: 0.006
-
Setty-Shah N, Maranda L, Candela N, Fong J, Dahod I, Rogol AD, Nwosu BU. Lactose intolerance: lack of evidence for short stature or vitamin D deficiency in prepubertal children. PLoS One. 2013; 8(10):e78653.
Score: 0.004
-
Frank GR, Fox J, Candela N, Jovanovic Z, Bochukova E, Levine J, Papenhausen PR, O'Rahilly S, Farooqi IS. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):191-4.
Score: 0.004
-
Fuchs Y, Candela N, Sung C, Weinstein T, Levine J. Splenic pseudoaneurysm in a child with hereditary pancreatitis. J Pediatr Gastroenterol Nutr. 2010 Jun; 50(6):686-7.
Score: 0.003